Abiopharma

🔍 Milligan Michael Lee (Executive)

Company: Neumora Therapeutics, Inc. (NMRA)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 175,000 shares of Stock Option (Right to Buy) at $1.52 per share (Derivative)
  Date: 2026-08-20 | Code: A | Expires: 2036-08-20 | equity_swap_involved: false | shares_owned_after: 175,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: 25% of the shares subject to the option vest on the first anniversary measured from August 20, 2026 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
• REMARKS: Title: Chief Financial Officer & Principal Accounting Officer